Abstract
Evidence has been obtained that a single protein, known to modulate classical complement activation, also acts as an inhibitor in the properdin or alternate complement pathway. A highly purified inactivator of the third component of complement (C3) from human serum inhibited the proteolysis of Factor B in the properdin system (glycine-rich beta-glycoprotein) by glycine-rich beta-glycoproteinase. The inhibition was by the enzymatic destruction of glycine-rich beta-glycoproteinase activity. The major fragment of C3, C3b, which is the only known substrate of the C3 inactivator, blocked the destruction of glycine-rich beta-glycoproteinase by the C3 inactivator. Thus, in its inhibition of the porperdin pathway, the C3 inactivator destroys both the active form of glycine-rich beta-glycoproteinase and a protein involved in the conversion of the zymogen form of this enzyme (proglycine-rich beta-glycoproteinase) to its active form. The increased susceptibility to infections in a patient homozygous for deficiency of the C3 inactivator demonstrates the biologic significance of this protein.
MeSH Terms
Adult
Animals
Antibody Specificity
Antigen-Antibody Reactions
Chromatography, Gel
Complement Inactivator Proteins
Female
Glycine/blood
Glycoproteins/blood
Homozygote
Humans
Immune Sera
Immune System Diseases/blood,genetics
Immunoelectrophoresis
Male
Peptide Hydrolases/blood
Phagocytosis
Properdin/metabolism
Protein Precursors
Rabbits/immunology
Chemicals
Complement Inactivator Proteins
Glycoproteins
Immune Sera
Protein Precursors
Properdin
Peptide Hydrolases
Glycine
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Alper C A
Rosen F S
Lachmann P J
References (16)
16 references, click to expand
-
Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies.
Anal Biochem. 1966 Apr;15(1):45-52
PMID: 5959431
-
Three naturally-occurring inhibitors of components of complement in guinea pig and rabbit serum.
J Immunol. 1967 Sep;99(3):582-9
PMID: 6051385
-
Alper CA, Rosen FS: Studies of the in vivo behavior of human C'3 in normal subjects and patients.
J Clin Invest. 1967 Dec;46(12):2021-34
PMID: 6074005
-
The demonstration in human serum of "conglutinogen-activating factor" and its effect on the third component of complement.
J Immunol. 1968 Apr;100(4):691-8
PMID: 5645214
-
Increased susceptibility to infection associated with abnormalities of complement-mediated functions and of the third component of complement (C3).
N Engl J Med. 1970 Feb 12;282(7):350-4
PMID: 4188976
-
Studies in vivo and in vitro on an abnormality in the metabolism of C3 in a patient with increased susceptibility to infection.
J Clin Invest. 1970 Nov;49(11):1975-85
PMID: 4097977
-
Isolation and properties of a glycine-rich beta-glycoprotein of human serum.
Biochim Biophys Acta. 1970 Dec 22;221(3):529-35
PMID: 5499437
-
Deficiency of C3 inactivator in man.
J Immunol. 1971 Jul;107(1):19-27
PMID: 4997111
-
The C3-activator system: an alternate pathway of complement activation.
J Exp Med. 1971 Sep 1;134(3 Pt 2):90s-108s
PMID: 4105810
-
C3b inactivator of man. II. Fragments produced by C3b inactivator cleavage of cell-bound or fluid phase C3b.
J Immunol. 1971 Sep;107(3):742-50
PMID: 4999095
-
Functional relationship of factor B in the properdin system to C3 proactivator of human serum.
J Immunol. 1971 Oct;107(4):1200-4
PMID: 5093780
-
Genetic aspects of the complement system.
Adv Immunol. 1971;14:251-90
PMID: 5003195
-
C3 proactivator convertase and its mode of action.
J Exp Med. 1972 Apr 1;135(4):1003-8
PMID: 4111773
-
Partial purification of a serum inhibitor of C'1-esterase.
J Biol Chem. 1961 Jun;236:1674-9
PMID: 13734157
-
The properdin system and immunity. XIII. Assay and properties of a heat-labile serum factor (factor B) in the properdin system.
Z Immun exp ther. 1959 Oct-Nov;118:349-57
PMID: 13801696
-
ANTIGEN-ANTIBODY CROSSED ELECTROPHORESIS.
Anal Biochem. 1965 Feb;10:358-61
PMID: 14302464